title: [Effect of dicarbamine on medullary hemopoiesis in experimental post-irradiation bone-marrow syndrome].
abstract: The effect of dicarbamine on hemopoiesis in experimental post-irradiation bone-marrow syndrome was studied. The myeloprotective activity of the drug was established. It manifested in the protection of hematopoietic progenitor cells and stimulation of cell proliferation and differentiation in the bone marrow.
authors.forename: I Ia
authors.initials: IIa
authors.lastname: Moiseeva
authors.forename: A I
authors.initials: AI
authors.lastname: Zinov'ev
authors.forename: L V
authors.initials: LV
authors.lastname: Ionicheva
authors.forename: S A
authors.initials: SA
authors.lastname: Nikishin
authors.forename: V E
authors.initials: VE
authors.lastname: Nebol'sin
authors.forename: Iu V
authors.initials: IuV
authors.lastname: Kinzirskaia
mesh_terms: D000818:Animals; D001853:Bone Marrow / Q000187:drug effects* / Q000528:radiation effects*; D002208:Caproates; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D006410:Hematopoiesis / Q000187:drug effects* / Q000528:radiation effects; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000528:radiation effects; D007093:Imidazoles / Q000494:pharmacology*; D020011:Protective Agents / Q000494:pharmacology*; D011817:Rabbits; D013577:Syndrome
chemical_list: D002208:Caproates; D007093:Imidazoles; D020011:Protective Agents; C539419:pentanedioic acid imidazolyl ethanamide